SCHEMBL33800

SCHEMBL33800

C[C@H](NC(=N)N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL33799 1.00
SCHEMBL2797317 1.00
Iodide SCHEMBL29117519 0.98 MME (0.38)
Hydrochloric Acid SCHEMBL11786713 0.98 MME (0.38)
Hydrochloric Acid SCHEMBL11786704 0.98 MME (0.38)
Acrylamide SCHEMBL27844908 0.88 ALDH1A1 (0.42)
Nitric Acid SCHEMBL28802756 0.88 ALDH1A1 (0.37)
Thiophene SCHEMBL27530939 0.84 ALDH1A1 (0.38)
SCHEMBL27811923 0.83 SMN1; SMN2 (0.35)
SCHEMBL5460549 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 760 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1991572-A2 PEPTIDES THAT BLOCK THE BINDING OF IGG TO FCRN SYNTONIX PHARMACEUTICALS, INC. (US) 2008-11-19 EP claimed
US-20070254831-A1 PEPTIDES THAT BLOCK THE BINDING OF IgG to FcRn BIOGEN HEMOPHILIA INC. 2007-11-01 US claimed
WO-2007098420-A2 PEPTIDES THAT BLOCK THE BINDING OF IGG TO FCRN SYNTONIX PHARMACEUTICALS, INC. (US) 2007-08-30 WO claimed
EP-0660709-A1 CREATINE ANALOGS HAVING ANTIVIRAL ACTIVITY AMIRA, INC. (US) 1995-07-05 EP claimed
WO-1993012781-A2 CREATINE ANALOGS HAVING ANTIVIRAL ACTIVITY AMIRA, INC. (US) 1993-07-08 WO claimed
US-12576015-B2 Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an alcohol compound, and cosmetic composition containing same L'OREAL (FR) 2026-03-17 US disclosed
US-12544322-B2 Dyeing composition comprising an anthraquinone cationic direct dye, a polyol, an anionic surfactant and a nonionic polysaccharide L'ORÉAL (FR) 2026-02-10 US disclosed
US-12521333-B2 Composition comprising compound of thiopyridinone type and polyglyceryl-based emulsifiers L'OREAL (FR) 2026-01-13 US disclosed
EP-4452203-B1 PROCESS FOR DYEING KERATIN FIBRES USING A COSMETIC COMPOSITION COMPRISING PROPANE-1,3-DIOL AND A DYEING COMPOSITION OREAL (FR) 2025-12-24 EP disclosed
US-12502341-B2 Method for the cosmetic treatment of keratin materials employing a rare earth metal composition and an alkaline composition L'OREAL (FR) 2025-12-23 US disclosed
US-20250381115-A1 STABILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME OREAL (FR) 2025-12-18 US disclosed
US-20250381116-A1 SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME OREAL (FR) 2025-12-18 US disclosed
EP-1532963-A1 Composition for straightening the hair comprising at least one imine not being an hydroxide L'OREAL (FR) 2005-05-25 EP disclosed
EP-0660709-A1 CREATINE ANALOGS HAVING ANTIVIRAL ACTIVITY AMIRA, INC. (US) 1995-07-05 EP disclosed
WO-1994016712-A9 CREATINE PHOSPHATE, CREATINE PHOSPHATE ANALOGS, AND USES THEREFOR 1994-09-15 WO disclosed
EP-0601001-A1 PHARMACEUTICAL COMPOSITION CONTAINING 3-GUANIDINOPROPIONIC ACID AND PIOGLITAZONE GLIBENCLAMIDE OR GLIMEPIRIDE. UPJOHN CO (US) 1994-06-15 EP disclosed
WO-1993012781-A2 CREATINE ANALOGS HAVING ANTIVIRAL ACTIVITY AMIRA, INC. (US) 1993-07-08 WO disclosed
US-4347310-A INCREASED PHOTOSENZITIVITY USING GUANIDINE DERIVTIVES AS SENSITIZERS; PHOTOSTABILITY; STORAGE STABILITY ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1982-08-31 US disclosed
US-3972872-A BACTERICIDE, ANIMAL FEED SUPPLEMENT PFIZER INC. (US) 1976-08-03 US disclosed
US-3933797-A 6-[α-(ω-QUANIDINOALKANOYLAMIDO)ACYLAMIDO]PENICILLANIC ACIDS PFIZER INC. (US) 1976-01-20 US disclosed